#LCSM Chat Topic 9/21: Patient-Clinician Communication in Cancer Care: Conflicting Ideals vs. Reality?
Jack West, MD For the upcoming #LCSM tweet chat on 9/21 at 8 PM Eastern, 5 PM Pacific, we’re going to focus on newly published guidelines for clinician-patient communication in cancer care, and we’ll have the added bonus of being joined for our chat by the lead author of these guidelines, Dr. Tim Gilligan from the Cleveland Clinic. By way of background, the American Society for Clinical Oncology (ASCO) just released a collection of guidelines for patient-physician communication, which is far reaching in describing clear goals for physicians and all clinicians… Read More
Original Photo by Unknown Author and this modified image are licensed under CC BY Although the average age for a lung cancer diagnosis is around 70 years old, an increasing number of younger patients are being diagnosed. Many of these younger patients have especially aggressive cancer, and have children at home. The patient or their spouse/partner may be uncertain about when and how to tell their child about cancer, and struggle with finding supports that help the children process the situation. On September 7 at 8 pm Eastern Daylight Time (5 pm… Read More
#LCSM Chat Topic 5/4 — The PDQ on MTBs: Why are multidisciplinary tumor boards important in #lungcancer?
Lung cancer is a complicated disease. Diagnosing and treating complex cases can require skills that cross a variety of medical specialties. Larger medical centers and hospitals may decide to discuss complex cases in tumor boards that include physicians that represent a variety of medical specialties. Our May 4, 2017, #LCSM Chat (at 8pm Eastern, 5pm Pacific) will focus on defining what a multidisciplinary tumor board (MTB) does, who is involved, and why MTB are important in the treatment of lung cancer. The National Cancer Institute defines a tumor board review as: A… Read More